Exelixis, Inc. (EXEL)
56.12
-1.31
(-2.28%)
USD |
NASDAQ |
Sep 11, 16:00
56.14
+0.02
(+0.04%)
After-Hours: 20:00
Exelixis 1 Year Total Returns (Daily) : 43.64% for Sept. 11, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| September 11, 2026 | 43.64% |
| September 10, 2026 | 52.33% |
| September 09, 2026 | 52.38% |
| September 08, 2026 | 53.01% |
| September 04, 2026 | 57.87% |
| September 03, 2026 | 59.98% |
| September 02, 2026 | 57.42% |
| September 01, 2026 | 52.03% |
| August 31, 2026 | 46.02% |
| August 28, 2026 | 43.67% |
| August 27, 2026 | 43.50% |
| August 26, 2026 | 46.32% |
| August 25, 2026 | 49.66% |
| August 24, 2026 | 41.21% |
| August 21, 2026 | 39.71% |
| August 20, 2026 | 41.81% |
| August 19, 2026 | 44.96% |
| August 18, 2026 | 40.68% |
| August 17, 2026 | 36.57% |
| August 14, 2026 | 33.19% |
| August 13, 2026 | 31.49% |
| August 12, 2026 | 32.75% |
| August 11, 2026 | 37.21% |
| August 10, 2026 | 40.40% |
| August 07, 2026 | 44.61% |
| Date | Value |
|---|---|
| August 06, 2026 | 38.42% |
| August 05, 2026 | 51.36% |
| August 04, 2026 | 52.13% |
| August 03, 2026 | 47.77% |
| July 31, 2026 | 46.41% |
| July 30, 2026 | 51.87% |
| July 29, 2026 | 49.78% |
| July 28, 2026 | 27.30% |
| July 27, 2026 | 22.39% |
| July 24, 2026 | 23.62% |
| July 23, 2026 | 22.58% |
| July 22, 2026 | 23.63% |
| July 21, 2026 | 26.80% |
| July 20, 2026 | 24.87% |
| July 17, 2026 | 24.63% |
| July 16, 2026 | 24.26% |
| July 15, 2026 | 26.08% |
| July 14, 2026 | 22.36% |
| July 13, 2026 | 24.92% |
| July 10, 2026 | 25.08% |
| July 09, 2026 | 29.57% |
| July 08, 2026 | 28.96% |
| July 07, 2026 | 29.26% |
| July 06, 2026 | 20.32% |
| July 02, 2026 | 26.07% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -46.93% |
| BioMarin Pharmaceutical, Inc. | 17.47% |
| Cytokinetics, Inc. | 38.35% |
| Emergent BioSolutions, Inc. | -24.30% |
| Gilead Sciences, Inc. | 25.13% |